June 1st, 2007
Wyeth’s New Kidney Cancer Drug Torisel™, Approved by the FDA
Wyeth Pharmaceuticals’ new kidney cancer drug Torisel™ (temsirolimus) has recently been approved by the FDA for the treatment of renal cell carcinoma - a type of advanced kidney cancer.
Torisel™ is an enzyme inhibitor (mTOR inhibitor to be exact) whose FDA approval came following results of prolonged survival in renal cell carcinoma patients.
According to Dr. Steven […]
Recent Comments